day 1 agenda

TENTATIVE PROGRAM
GICBC-2026(June 29-30, 2026)
Registrations Open
Opening Ceremony
KEYNOTE TALKS
Title: TBA
Dipanjan Pan, The Pennsylvania State University, USA
 
Title: Impact of body mass index on the surgical outcomes and delayed adjuvant treatment in patients undergoing therapeutic mammoplasty for breast cancer
Maged Hussien, Norfolk and Norwich University hospital, United Kingdom
Plenary Talk
Title: A novel HER2 protein identification methodology in breast cancer cells using Raman spectroscopy and raman imaging: an analytical validation study
Halina Abramczyk, Lodz University of Technology, Poland
 
SPEAKER PRESENTATIONS
 
Title: Growth inhibitory effect of Leptospermum scoparium (manuka) chloroform extract on breast and liver cancer cell lines
Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia
 
Title: A case of tubercular granulomatous mastitis- a different management technique
Bharati Pandya, AIIMS Bhopal, India
 
Title: TBA
Atziri Corin Chavez Alvarez, Université Clermont-Auvergne, France
 
Title: Shaping the Future: AI-Driven Solutions in Breast Reconstruction
Edward Ray,Cedars-Sinai Medical Center, USA
 
Title: HER2 amplification by next-generation sequencing to identify her2-positive invasive breast cancer with negative her2 immunohistochemistry
Ying S. Zou, The Johns Hopkins University, USA
 
Title: Relationship between diagnostic characteristics, lifestyle habits and breast cancer subtypes in women
Fernanda Cristina Marin, Escola de Enfermagem da Universidade de São Paulo, USA
 
Title: PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence
Haiying Zhan, Yale University, USA
 
Title: The Causal Effect of 24-hour Activity Patterns in Adulthood on Breast Cancer Risk Among Polish Migrant Women in US
Azam Najaf Kouchak, Michigan State University, USA
 
Title: Dissecting Notch-driven EMT programs at single-cell resolution in breast cancer
Magdalena Orzechowska, Medical University of Lodz, Poland
 
Title: TBA
Jukka H. Meurman, University of Helsinki and Helsinki University, Finland
 
Title: TBA
Christina M. Dieli-Conwright, Harvard Medical School, USA
 
Title: TBA
Hongxi Yao, Guangyuan Central Hospital, China
 
Title: Mechanisms of Action of FDA-Approved Endocrine Therapies for ER-Positive Breast Cancer
Kiven Erique Lukong, University of Saskatchewan, Canada
 
Title: Effect of chemotherapy timing in triple?negative breast cancer: a real?world evidence study
Maycos Leandro Zapata Muñoz, Universidad de Antioquia, Colombia
 
Title: A Case of Grade II Breast Mucinous Carcinoma Progression from Ductal Carcinoma in Situ
Clara Straus, St. John's Episcopal Hospital, USA
 
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org  

day 2 agenda

Day -2: June (30, 2025)
Keynote Session (09:00- 10:50)
     
Refreshment Break (10:50-11:00)
     
Morning Session: (11:00 - 13:00)
     
Lunch Break (13:00-14:00)
     
Afternoon Session: (14:00 - 16:00) 
     
Refreshment Break (16:00-16:10)
     
Evening Session: (16:10 - 18:00)
     
End Note Session and Closing Ceremony
If any one interested to attend the conference or to book your speaker slot, please send an email to: breastcancer@innovinc.org 

Virtual agenda

Updating Soon...

Download